BNVA 150 (Boniva 150 mg)
Generic Name: ibandronate
Pill with imprint BNVA 150 is White, Elliptical / Oval and has been identified as Boniva 150 mg. It is supplied by Roche Laboratories.
Boniva is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Boniva 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BNVA 150
Boniva
- Generic Name:
- ibandronate
- Imprint:
- BNVA 150
- Strength:
- 150 mg
- Color:
- White
- Size:
- 14.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Roche Laboratories
- Inactive Ingredients:
- lactose monohydrate
povidone k25
microcrystalline cellulose
crospovidone
stearic acid
silicon dioxide
water
hypromelloses
titanium dioxide
magnesium silicate
polyethylene glycol 6000
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 54868-5322 | Physicians Total Care Inc. (repackager) |
| 35356-0423 | Lake Erie Medical and Surgical Supply (repackager) |
More about Boniva (ibandronate)
- Boniva Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 41 Reviews
- Generic Availability
- Drug class: bisphosphonates
Consumer resources
- Boniva
- Boniva (Ibandronate Injection)
- Boniva (Ibandronate Tablets)
- Boniva (Advanced Reading)
- Boniva Intravenous (Advanced Reading)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
